Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

ABM 1383

Next Previous
X
Search
Drug Profile

ABM 1383

Alternative Names: ABM-1383

Latest Information Update: 30 Sep 2020

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator ABM Therapeutics
  • Class Antineoplastics; Small molecules
  • Mechanism of Action Mitogen-activated protein kinase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • Preclinical Cancer

Most Recent Events

  • 30 Sep 2020 ABM 1383 is available for licensing as of 30 Sep 2020. http://www.abmtx.com/
  • 30 Sep 2020 ABM Therapeutics plans clinical development in Cancer (Combination therapy, Metastatic disease) (ABM Therapeutics pipeline, September 2020)
  • 30 Sep 2020 ABM Therapeutics plans to file an IND application for prospective clinical development in Cancer (Combination therapy, Metastatic disease) in 2020 (ABM Therapeutics pipeline, September 2020)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top